Search

(Abstracted from Obstet Gynecol2022;140:121–131)Early detection and targeted treatment of human disorders are the goal of precision medicine. The advancing technology of cell-free DNA (cfDNA) is increasingly being applied in screening, diagnosis, and treatment of several disease processes.

This article outlines a framework for the process of genetic counseling in the primary obstetric and gynecologic setting. Specifics regarding risk assessment, family history evaluation, genetic testing, and pretest and posttest counseling are discussed. Additionally, the article provides strategies for counseling patients effectively and addresses when a referral for additional genetic counseling by a specialized genetics provider should be considered.